The target audience includes family physicians and internal medicine physicians, along with community pulmonologists, physician assistants, advanced practice nurses, registered nurses, respiratory therapists, pharmacists and other health care professionals who diagnose and treat patients with idiopathic pulmonary fibrosis (IPF).